Introduction
Grb2 is an adapter protein composed nearly exclusively of Src homology 2 and 3 (SH2 and SH3) domains. It has the structure SH3-SH2-SH3 (reviewed in Chardin et al. 1995; Takenawa et al. 1998; Buday 1999 ). Grb2 became a focus point of great interest after studies in C. elegans had identi®ed the Grb2 homologous Sem-5 protein as a crucial upstream signal transducer of Let-60 (C. elegans homolog of Ras; Clark et al., 1992) . Shortly thereafter, a¯urry of publications documented that mammalian Grb2 can bind to activated receptors via its SH2 domain, thereby translocating the Rasspeci®c guanine nucleotide exchange factor SoS to plasma membrane, leading to the GTP-loading of Ras (Bowtell et al., 1992; Lowenstein et al., 1992; RozakisAdcock et al., 1992 RozakisAdcock et al., , 1993 Buday and Downward, 1993; Chardin et al., 1993; Egan et al., 1993; Li et al., 1993; Simon et al., 1993) . This triggers the activation of the central mitogenic MAP kinase cascade (Raf-MEK-MAPK/Erk; reviewed in Robinson and Cobb, 1997; Reuther and Der, 2000) .
The Grb2 SH2 domain can bind to dierent growth factor and other receptors directly through tyrosine phosphorylated motifs which usually conform to the consensus pY-x-N-x. Alternatively, the Grb2 SH2 domain can bind to the adapter protein Shc which mediates the indirect docking of Grb2 to some receptors. The N-terminal SH3 domain of Grb2 [SH3(N)] binds SoS, Cbl, dynamin, HPK1 and other proteins or peptides via motifs conforming to the consensus P-x-x-P-x-R (Sparks et al., 1996; Oehrl et al., 1998; and references therein) . Ultrastructures of the Grb2 SH3(N) domain in complex with a speci®c binding peptide derived from SoS have shown that the binding peptide has the conformation of a type II polyproline helix (Goudreau et al., 1994; . The SoS peptide has also been analysed by co-crystalization and X-ray diraction in complex with the Grb2 SH3(C) domain . However, a consensus motif for high anity binding of Grb2 SH3(C) has not been described. From a number of studies it is clear that at least some SH3 domains can bind in vitro proline-rich peptides in two orientations, designated as class I and class II binding peptides. This is also true for the Grb2 SH3(N) domain (Sparks et al., 1996 , and references therein). The Grb2 SH3(N) interactions via P-x-x-P-x-R motifs (class II binding) appear at present more important for the in vivo functions of Grb2. Targeted disruption of the grb2 gene in mice leads to early embryonic lethality .
In addition to Grb2, several homologous adapter proteins with a highly similar domain composition have been published. While Grb2 is ubiquitously expressed, GRAP (Grb2-related adapter protein) and Mona (Monocytic adapter; also cloned as Gads, Grf40, GRID, GrpL, Grap-2, GrbX, GrbLG) are apparently restricted to hematopoietic cells (Feng et al., 1996; Bourette et al., 1998; Liu and McGlade, 1998; Qiu et al., 1998; Asada et al., 1999; Law et al., 1999; Ellis et al., 2000) . GRAP and Mona are less well studied than Grb2, but appear to play a role in T cell receptor signaling (reviewed in Clements et al., 1999) and possibly the regulation of myeloid cell development (Bourette et al., 1998) . A truncated form of the exchange factor Vav which has the same domain composition as Grb2 (SH3-SH2-SH3) and designated as Vav3.1 was also just reported (Trenkle et al., 2000) .
Recent analyses of Gab1 binding to Grb2 strongly suggested that Grb2 SH3 binding motifs should exist which do not even contain the core sequence P-x-x-P typical for the binding sequences of most SH3 domains (Schaeper et al., 2000) . Moreover, the Gab1 region mapped as Grb2 binding site is homologous to a region of the adapter protein SLP-76.
In this study crucial residues in the proteins Gab1 and SLP-76 for a high anity binding to the Grb2 SH3(C) domain are de®ned. Analysis of other proteins with similar motifs helped to de®ne a novel and highly unusual binding consensus for this domain. Finally, comparison of sequence motifs from proteins binding to Grb2 SH3(C) with proteins binding to the related adapter protein Mona led to the prediction of a similar but distinct binding consensus for this related adapter protein.
Results

Gab1 and SLP-76 bind efficiently to the C-terminal SH3 domain of Grb2
Previous studies have reported that Gab1 can bind to the adapter protein Grb2 in vivo (Holgado-Madruga et al., 1996; Fixman et al., 1997; Schaeper et al., 2000) . Moreover, the Grb2 binding site of Gab1 was mapped to a region which has signi®cant homology to SLP-76, another well known Grb2 binding protein (Jackman et al. 1995; Motto et al., 1996; Schaeper et al., 2000) . The details of the interaction remained unclear however.
In initial experiments, it was found that Gab1 and SLP-76 bound strongly to the C-terminal SH3 domain of Grb2 [SH3(C)] but not to its N-terminal SH3 domain (Figure 1 ). The intensively studied Grb2 binding proteins SoS (Buday and Downward, 1993; Chardin et al., 1993; Egan et al., 1993; Li et al., 1993; Rozakis-Adcock et al., 1993; Simon et al., 1993) and cCbl (Donovan et al., 1994; Fukazawa et al., 1995; Odai et al., 1995; Lupher et al., 1999) were also analysed simultaneously to con®rm the functionality of the SH3 domains used. c-Cbl and SoS can bind to the Nterminal SH3 domain of Grb2, but also to the Cterminal Grb2 domain, as reported in prior publications Park et al., 1998) .
Gab1 binds directly to the C-terminal SH3 domain but not to the N-terminal SH3 domain of Grb2
The primary sequence of Gab1 contains motifs which conform to the Grb2 SH3(N) binding consensus P-x-x-P-x-R. However, Gab1 did not bind to in precipitation experiments (Figure 1) . A possible explanation for this lack of binding could be the presence of highly stable protein complexes in cell lysates between Gab1 and the N-terminal SH3 domain of Grb2. This would prevent exogenously added GSTGrb2 SH3(N) from binding to Gab1. This explanation seems unlikely since the residues surrounding the P-x-x-P-x-R core motif are quite dierent from those found in known high anity binding sequences. However, to fully exclude high anity Gab1 ± Grb2 SH3(N) complexes, recombinant Gab1 protein puri®ed from E. coli was tested for binding to the Grb2 SH3(N) domain ( Figure 2a ). As expected, no binding beyond background was seen with the Grb2 SH3(N) domain while the SH3(C) domain bound with great eciency. The functionality of the Grb2 SH3(N) domain protein used for the precipitation was con®rmed by precipitation of the known Grb2 SH3(N) binding proteins c-Cbl and SoS, followed by Far Western blotting with 35 S-labeled A 13 amino acid motif in SLP-76 is sufficient for high affinity binding to the Grb2 SH3(C) domain
To de®ne the binding site of SLP-76 for the Grb2 SH3(C) domain, dierent peptides from the region of homology between human SLP-76 and Gab1 were synthesized and tested for binding to the SH3(C) domain by tryptophan¯uorescence (Table 1) . This method allows a highly reliable quanti®cation of binding anities for many SH3 domain ± peptide interactions Knudsen et al., 1995; and others) . A 13 amino acid peptide corresponding to amino acids 231 ± 243 of human SLP-76 was found to bind with a K d of approximately 20 mM to Grb2 SH3(C) while longer peptides of 21 and 31 amino acids bound half-maximal at 7 and 14 mM, respectively. These are typical anities for short peptides synthesized after biologically relevant binding sites of SH3 domains. By contrast, a point mutant peptide with a single arginine mutated to lysine [SLP-76 peptide amino acids 231 ± 243(R237K)] did not bind to the Grb2 SH3(C) domain anymore, indicating a highly selective interaction of the wildtype SLP-76 peptide. Further studies (see Table 2 ) indicate that a Px-x-x-R-x-x-K-P motif corresponds to the residues that are most important for Grb2 SH3(C) binding. It is therefore already highlighted in Table 1 .
Point mutations in Gab1 define the Grb2 binding region
In parallel to these measurements with synthetic peptides, a mutagenesis analysis was carried out with the Gab1 region previously mapped as a prominent Grb2 binding site (Schaeper et al., 2000) . Point mutants were introduced by PCR in a murine Gab1 fragment (amino acids 416 ± 570) containing the SLP-76 homology region. By performing a widely used colorimetric yeast two-hybrid binding assay (Chien et al., 1991) , the consequences of various point mutations Figure 2 Direct binding to Gab1 by the Grb2 SH3(C) domain but not the Grb2 SH3(N) domain. (a) A Gab1 protein with a deleted PH domain (Gab1DPH) was expressed in E. coli and puri®ed as described in Materials and methods. This protein was then used in precipitation experiments with immobilized SH3 domains of Grb2. Bound Gab1DPH was detected after SDS ± PAGE and blotting with anti-Gab1. (b) SH3 domains of Grb2 were metabolically labeled with 35 S-Cys and -Met according to standard protocols (Feller et al., 1995b) . Protein integrity and labeling eciency was detected by SDS ± PAGE and Coomassie-staining followed by autoradiography. Table 2 . Most mutations generated strongly suppressed the binding of the Gab1 fragment (amino acids 416 ± 570) to Grb2 in vivo, indicating the importance of this epitope for the interaction. A four amino acid replacement in the Gab1 sequence with corresponding amino acids from SLP-76 resulted in a chimeric Gab1 protein which still bound well to Grb2 in the yeast two-hybrid assay, con®rming the results obtained with the synthetic peptides ( Table 1) .
Determination of Grb2 SH3(C) binding peptide affinities and affinities of mutant peptides by tryptophan fluorescence
Subsequently, the SLP-76/Gab1 homology region was synthesized as a peptide and quantitatively analysed for binding anity by tryptophan¯uorescence. A 13 amino acid wildtype peptide comprised of amino acids 517 ± 529 in human Gab1 bound with an anity slightly better than the corresponding SLP-76 peptide (Table 3) in agreement with the data obtained with murine Gab1 using the yeast two-hybrid assay (see Table 2 ). Comparison of dierent batches of peptide and anity puri®ed GST-Grb2 SH3(C) protein showed that it is possible to obtain highly reproducible binding anity measurements with¯uorescence spectroscopy, thus allowing a reliable detection of anity dierences which are less than two-fold (Table 3) . No binding of this peptide to the Grb2 SH3(N) domain was detectable by Trp-¯uorescence. Mutation of amino acids which are conserved between SLP-76 and Gab1 often resulted in a completely failure of the peptides to bind to the Grb2 SH3(C) domain (mutant peptides P519S, K526M, P527L). There were however, some notable exceptions, namely the mutant peptide Gab1 (R523A) which bound approximately 4.5-fold weaker than the wildtype sequence and the D522K mutant which did not show signi®cantly reduced binding, despite the exchange of the negatively charged Asp with positively charged Lys. These results suggest that there is considerable¯exibility in the arginine of the P-x-x-x-R-x-x-K-P motif and that the position preceding the arginine has only a small bias. The Grb2 SH3(C) domain does, however, not tolerate proline in this position, which presumably leads to a kink in the peptide conformation (D522P mutant).
A second motif is present in Gab1 in which the ®rst proline of the P-x-x-x-R-x-x-K-P motif is exchanged for an isoleucine. The corresponding peptide Gab1 peptide 2 (338 ± 350) displayed signi®cant albeit weaker binding to the Grb2 SH3(C) domain, indicating that there is no absolute requirement for a proline in this position. The Gab1 homologous protein Gab2 also has two similar motifs (amino acids 348 ± 360 and 509 ± 521). Synthetic peptides made after these sequences from Gab2 both showed strong binding to the Grb2 SH3(C) domain. Again, one Gab2-derived peptide (amino acids 348 ± 360) lacks the ®rst proline which is replaced by alanine. Nevertheless it bound strongly to the Grb2 SH3(C) domain.
In prior studies it was found that a murine SoSderived peptide which binds strongly to the Grb2 SH3(N) domain can also bind to the Grb2 SH3(C) domain Cussac et al., 1999) . This peptide is known to form a typical type II polyproline helix and contains the P-x-x-P-x-R motif typically found in good Grb2 SH3(N) binding motifs (indicated by ®lled arrow heads below the peptide). It lacks, however, a strong homology to the Gab1 binding peptides and can only be aligned to ®t the ®rst half of the P-x-x-x-R-x-x-K-P motif. Therefore, the anity of the SoS peptide (murine SoS amino acids 1135 ± 1145) was compared with the Gab1-and Gab2-derived peptides. It was found that the SoS peptide binds approximately eight times weaker than the best binding sequence from the Gab proteins (Table 3) . On the other hand, another SoS derived peptide with a leucine instead of the lysine in the P-xx-x-R-x-x-K-P motif (human SoS amino acids 1203 ± 1145) did not bind at all according to our Trpuorescence measurements, suggesting that the`K-P' part of the P-x-x-x-R-x-x-K-P motif is crucial for binding. This apparent discrepancy can be resolved by the assumption, that two very distinct binding peptide grooves exist on the surface of the Grb2 SH3(C) domain. Although we have not yet studied the conformation of the Grb2 SH3(C) binding peptides from SLP-76 and the Gab proteins, their sequences have no high content of prolines and may not form a type II helix which would also argue for a rather distinct binding groove. With future ultrastructural studies of SH3-peptide complexes it should be possible to get clear answers for this.
Since c-Cbl is a well known Grb2 binding protein which can bind to both SH3 domains with some anity (Donovan et al., 1994; Kohda et al., 1994 ; 
Gab1 prey vectors encode amino acid 416 ± 570 of wild type Gab1 or of the Gab1 mutants indicated. In Gab1/SLP-76, the Grb2 binding site of Gab1 is substituted with the putative Grb2 binding site of SLP-76 (Schaeper et al., 2000) . Interactions of Gab1 mutants with full size Grb2 bait were quanti®ed by b-galactose liquid assay and compared to the association of Gab1 (416 ± 570) with Grb2 set as 100%
Oncogene Novel Grb2 SH3(C) domain binding motifs M Lewitzky et al Fukazawa et al., 1995; Odai et al., 1995; Park et al., 1998 ; see also Figure 1 ), Cbl-derived sequences were also tested for binding to the Grb2 SH3(C) domain. Two peptides were synthesized, corresponding to amino acids 534-546 and 816-828. As expected, only Cbl peptide which contains the P-x-x-x-R-x-x-K-P motif bound to the SH3(C) domain, again pointing to the importance of the lysine preceeding the last proline (Table 3) .
To further test our hypothesis we investigated additional candidate sequences from signal transduction proteins known to bind to Grb2 or Grb2-like adapter proteins. A search of the protein databases SwissProt and TrEMBL with the P-x-x-x-R-x-x-K-P consensus revealed that the recently cloned signal transduction protein AMSH (for associated molecule with the SH3 domain of STAM; Tanaka et al. 1999) also contains this motif. AMSH has also just been reported to be a yeast two-hybrid interaction partner of the Grb2-homologous protein Mona (syn. Grf40; Asada et al., 1999) . Indeed, the corresponding AMSH peptide bound strongly to the Grb2 SH3(C) domain (Table 3) .
Sequences from the hematopoietic progenitor kinase 1 (HPK1), another known Grb2 binding protein recently reported to bind to Mona (Liu et al., 2000) were also tested. HPK1 has been shown to bind to Gab1 competitor peptide (aa 517 ± 529; EPPPVDRNLKPDR) or point mutant control peptide (EPPPVDRNLMPDR; Gab1K526M) as indicated and subsequently incubated with 30 mg of GST-Grb2 SH3(C). The fusion protein was recovered with GSH-beads and probed for bound Gab1 as before Novel Grb2 SH3(C) domain binding motifs M Lewitzky et al both SH3 domains of Grb2, albeit much weaker to the Grb2 SH3(C) domain (Oehrl et al., 1998) . It lacks a full P-x-x-x-R-x-x-K-P motif but contains several epitopes which correspond partially to it. There are two sequences which lack the lysine but contain both anking prolines and the central arginine. Both sequences did not bind detectably to the Grb2 SH3(C) domain. Another epitope lacks the arginine but retains the two prolines and the lysine. This peptide could not be measured by Trp-¯uorescence since the sequence contains a tryptophan, resulting in a very strong background¯uorescence change with each peptide addition. Instead, a competition assay was performed (discussed further below).
Peptides from Gab1, Gab2, SLP-76 and AMSH prevent the formation of Grb2 SH3(C) ± Gab1 complexes Another series of experiments analysed if the P-x-x-x-Rx-x-K-P consensus-containing peptides could prevent the SH3(C) domain from binding to the native Gab1 extracted from human embryonic kidney cells (HEK293). As already shown in Figure 1 , GST-Grb2 SH3(C) fusion protein immobilized on beads, eciently precipitated Gab1 from the 293 cell protein extracts. Addition of the wildtype Gab1 peptide (amino acids 517 ± 529) into the cell lysate reduced in a dosedependent manner the binding of Gab1 to the Grb2 SH3(C) domain (Figure 3 ). By contrast, the point mutant peptide Gab1(K526M) which did not bind to the Grb2 SH3(C) domain according to Trp-¯uorescence measurements (Table 3 ) also did not inhibit Gab1 binding to the Grb2 SH3(C) domain (Figure 3 ). This assay was subsequently used to test further peptides previously analysed by Trp-¯uorescence. Comparison of the Gab1 wildtype peptide and the Gab1 mutant peptide (D522K) showed that the D522K mutant was equally ecient in preventing Gab1 from binding to the Grb2 SH3(C) domain (Figure 4 ). This is in agreement with the results from the Trp-¯uorescence measurements (Table 3 ). The SLP-76 peptide (amino acids 231-243) prevented very eciently the binding of Gab1, while the SLP-76 (R237K) mutant did not, again consistent with the Trp-¯uorescence results (Figure 4) . Testing of the Gab2 peptides showed that Gab2 peptide 1 (amino acids 509 ± 521) was very ecient in preventing Gab1 from binding to the Grb2 SH3(C) domain. The Gab2 peptide 2 (amino acids 348 ± 360) also showed some ability to prevent complex formation, albeit weakly. This was unexpected, since both Gab2-derived peptides bound with nearly the same anity to the Grb2 SH3(C) domain in the Trp-¯uorescence assay. One possible explanation is that the binding of the two Gab2 peptides diers signi®cantly in their`o' rate. From the stability of the Gab1 ± Grb2 SH3(C) complex under high stringency washing conditions (RIPA 100; see Figure 1 ) it is likely that these proteins remain tightly bound together once the complex is formed. A peptide which binds only brie¯y to the Grb2 SH3(C) domain (high`o' rate) may therefore not eciently prevent the formation of Gab1 ± Grb2 SH3(C) complexes under assay conditions used here (duration of competitive incubation 90 min). In the Gab2 peptide 2, the ®rst proline of the P-x-x-x-R-x-x-K-P motif is replaced by alanine. Whether this amino acid change is responsible for the observed low competition eciency remains to be determined. The peptide synthesized after the motif contained in AMSH (amino acids 229 ± 241) was again able to prevent very eciently the formation of Gab1 ± Grb2 SH3(C) complexes (Figure 4) , consistent with its high anity binding in the Trp-¯uorescence assay (Table 3) . By contrast, two peptides from HPK1 which lack the lysine of the P-x-x-x-R-x-x-K-P motif (amino acids 359 ± 371 and 432 ± 444; see Table 3) were not able to prevent protein binding to the Grb2 SH3(C) domain, even in very high concentrations (600 mg/ml), consistent with the negative binding results from the Trp-¯uorescence measurements (Table 3) . A partial eect was seen with the third HPK1 peptide which lacks the arginine of the consensus motif (amino acids 459 ± 471; see Table 3 for sequence), but only at very high concentrations (data not shown). Since HPK1 binds apparently weakly to the SH3(C) domain and much better to the SH3(N) of Grb2 (Oehrl et al., 2000) , this site may primarily serve as an enhancer of the prominently Grb2 SH3(N) mediated binding. However, further analysis of HPK1 will be necessary to exclude other possibilities.
Discussion
It is shown here that the C-terminal SH3 domain of Grb2 binds to several signaling proteins which contain the novel and unusual consensus motif P-x-x-x-R-x-x-K-P. Deviations from this consensus appear to be tolerated only in the ®rst half of the motif (P-x-x-x-R) while the`K-P' part of the consensus motif is apparently crucial for the interaction. Tables 1 and 3 ) and subsequently incubated with GST-Grb2 SH3(C) and GSH-beads. After washing, bound Gab1 protein was detected as before Oncogene Novel Grb2 SH3(C) domain binding motifs M Lewitzky et al Previously reported Grb2 SH3(C) binding proteins, like RPTP-a (den Hertog and Hunter, 1996) , CD28 (Kim et al., 1998; Okkenhaug and Rottapel, 1998) , Disabled-2 (Dab-2; Xu et al., 1998) , MEK kinase-1 (MEKK-1; PomeÂ rance et al., 1998), TNF-receptor I (Hildt and Oess, 1999) and N-Wasp (Carlier et al., 2000) had not helped to de®ne a clear binding consensus for this SH3 domain. While many of these reported Grb2 SH3(C) binding proteins contain LysPro (`K-P') motifs, this is clearly not enough to de®ne the requirements for high anity binding to this domain. A direct involvement of`K-P'-containing motifs is suggested in the interaction of the TNFreceptor with the Grb2 SH3(C) domain in the report of Hildt and Oess (1999) . A peptide with the sequence TTKPLAP was able to inhibit this interaction, while a mutant control peptide TTKKLAP was not. Nevertheless, it seems at present that some reported Grb2 SH3(C) binding proteins do not bind via a region that contains the minimal`K-P' motif. For example, the CD28 region binding to the Grb2 SH3(C) domain has been analysed and does not contain a`K-P' motif (Okkenhaug and Rottapel, 1998) .
Several explanations could account for the apparent heterogeneity of the sequences contained in the reported Grb2 SH3(C) binding proteins. Firstly, it is well known that SH3 domains can bind type IIpolyproline helices in two orientations (class I and class II peptides). Secondly, the binding motifs found in Gab1 and SLP-76 do not appear to be good candidate sequences to promote the formation of a polyproline helix. Therefore, we believe that at least three, if not more, distinct types of peptide classes may be able to bind to the Grb2 SH3 domains with considerable anity. Moreover, it should be kept in mind that Grb2 has two SH3 domains which can both bind to the same protein simultaneously, hence abolishing an absolute requirement for high anity binding to one given SH3 domain. Further quantitative binding and mutagenesis studies with sequences from the not yet thoroughly analysed Grb2 SH3(C) binding proteins will be necessary to better de®ne the binding modalities on a case by case basis. De®nitive answers may, however, for some proteins only come from the generation of ultrastructural models of SH3-peptide/protein complexes by NMR or X-ray crystallography.
A database search using the motif P-x-x-x-R-x-x-K-P yielded more than 100 hits, often listing yet totally noncharacterized protein fragments. Most notable was the putative signal transduction protein AMSH, which was con®rmed in this study to contain a sequence motif that can bind to the Grb2 SH3(C) domain with high anity in vitro (Table 3 and Figure 4 ). Several signal transduction proteins with this motif remain to be tested, including the SLP-76 homologous protein BLNK (syn. SLP-65, BASH) and RIL (reversioninduced LIM protein), a protein induced by v-Jun and down-regulated by oncogenic Ras (Kiess et al., 1995; Fu et al., 2000) . While this manuscript was under initial review, another study describing a similar Grb2 SH3(C) binding consensus was published by Lock and colleagues (Lock et al., 2000) .
Despite the large number of previous studies with a focus on Grb2 it is only now becoming apparent that the C-terminal SH3 domain of Grb2 can mediate an important and distinct function from the Grb2 SH3(N) domain. In the case of c-Met receptor complex formation with Gab1, it appears that the SH2 domain and the C-terminal SH3 domain of Grb2 as well as the MBD domain of Gab1 mediate a stable complex. In principle, the Grb2 SH3(N) domain could remain free in this complex to perform additional protein ± protein interactions. However, it is currently not clear whether SH3(N)-dependent interactions are also coexistent and whether they are crucial for correct signaling of the HGF-receptor.
From the many previous reports it is quite clear that the SH3 domain is an ancient protein fold species which is not only present in hundreds of eucaryotic proteins, but also found in bacterial and viral proteins (Eijkelenboom et al., 1995; Whisstock and Lesk, 1999) . Therefore, it is not too surprising that the potential of this protein interaction domain has been utilized through the acceptance of several completely distinct yet highly speci®c, well de®ned binding motifs. Although the majority of SH3 domains appear to bind sequences which contain the core motif P-x-x-P, several interesting exceptions from this common theme have been reported. The SH3 domain of p53BP2 binds a motif composed of two discontinuous stretches of amino acids which loop together in space (Gorina and Pavletich, 1996) . The Eps8 SH3 domain was shown to bind peptides with the consensus P-x-x-D-Y-(Mongiovi et al., 1999) and the SKAP55 SH3 domain binds peptides which contain an R-K-x-x-Y-x-x-Y motif (Kang et al., 2000) . Moreover, SH3 domains can be regulated by post-translational modi®cations like tyrosine phosphorylation (Park et al., 1996) , or they exist as intertwined dimers (Kishan et al., 1997) . SH3 domains can even accommodate in their binding pocket(s) non-natural amino acids with very high anities and selectivities (Nguyen et al., 1998 (Nguyen et al., , 2000 , possibly allowing improvement on natures best binding motifs.
SH3 domains have also become recognized as potential targets for disease intervention (Brugge, 1993; Kardinal et al., 2000) . While small compounds with impressive SH3 domain blocking activity are still missing, several laboratories, including our own, have successfully introduced SH3 domain binding sequences into living cells to modulate signal transduction events. In the case of Grb2, a recent report showed that a peptide which can interact with both SH3 domains of Grb2 has superior biological activity compared to a peptide targeting just one of the domains (Cussac et al. 1999) . This study used a binding motif for the Grb2 SH3(C) domain which is derived from the Grb2 SH3(N) domain binding sequence of the SoS protein and has a signi®cantly lower anity for Grb2 SH3(C) than the new binding peptides described here (see Table 3 for anities). The results presented are (Figure 5 ). While the adapter proteins Mona and GRAP are restricted to hematopoietic cells, Grb2 is apparently ubiquitously expressed. The coexpression of several Grb2 family adapters in hematopoietic cells raises the issue of a potential competition of these related adapter proteins for binding proteins within cells.
Recently, a number of proteins which bind to Mona have been identi®ed (Liu et al., , 2000 Asada et al., 1999; Ellis et al. 2000) . Sequence analyses of these proteins revealed that Mona may bind to a sequence motif similar, yet distinct from the motif determined in this study for the Grb2 SH3(C) domain. The results are summarized in Figure 5 . The possible consensus sequence shown in Figure 5 is also supported by its presence in several newly identi®ed Mona SH3 binding proteins which are currently under investigation (Lewitzky et al., in preparation) . However, due to unknown reasons we have been unable to detect by tryptophan¯uorescence any peptide binding to a GST-fusion protein of the Mona SH3(C) domain which has been con®rmed to be functional in other assays (Lewitzky and Feller, unpublished data) . Therefore we cannot exclude the possibility that the presence of multiple P-x-x-x-R/K-x-x-x-P motifs in SLP-76 and other Mona binding proteins is due to other reasons. This dierent interpretation is supported by the fact, that the P-x-x-x-R/K-x-x-x-P motif appears in multiple repeats as clusters in quite a few proteins in the databases.
Figure 5 Domain composition and proposed consensus sequences for peptide binding to the SH3(C) domains of Grb2 family adapter proteins. Sequence identity between Grb2, Mona and GRAP is around 50% within the SH2 and SH3 domains. Note that the SLP-76 protein, which binds much stronger to Mona (Gads) than Grb2 contains one motif which conforms to the consensus Grb2 SH3(C) binding consensus P-x-x-x-R-x-x-K-P but seven motifs which contain the motif P-x-x-x-(R/K)-x-x-x-P
Materials and methods
Peptide synthesis
Synthesis was carried out as previously described (Kardinal et al., 2000) . The crude peptides were puri®ed by reverse-phase HPLC on preparative Vydac C18 columns. Correct mass was checked by mass spectrometry (Sciex API III, Perkin Elmer).
Tryptophan fluorescence spectrometry
The measurement of binding anities based on the interaction of the peptides with aromatic residues in the SH3 domains, predominantly tryptophan, was performed as previously described Knudsen et al., 1995; Posern et al., 1998; Kardinal et al., 2000) on a LS50B spectrometer (Perkin Elmer) with a water-cooled cuvette chamber. Brie¯y, 50 mg of GST-SH3 fusion protein in 3 ml of 16PBS pH 7.4 with 1 mM dithiotreitol was gently mixed in the spectrometer cuvette by a small magnetic stir bar until a temperature equilibrium (218C) was reached, as indicated by a constant Trp-¯uorescence base line (excitation 290 nm, emission 345 nm). Peptides (5 mg/ml in H 2 O) were then added and the incubation was continued until another uorescence plateau was reached. Stepwise peptide application was continued until no further change in¯uorescence (except for dilution eects) occurred, indicating the saturation of the SH3 domain peptide binding pocket. Calculation of binding was done with the Origin 4.1 software (Microcal, Northampton, MA, USA).
Yeast twohybrid analysis
Two-hybrid experiments were carried out in L40 yeast with VP16-murine Gab1 prey vectors and BTM-murine Grb2 bait vector as described previously (Schaeper et al., 2000) . Some point mutations in Gab1 prey vectors (P519L, V520A, D521A and P526L) were generated by PCR using oligonucleotides that encode the respective amino acid substitutions. The putative Grb2 binding site of SLP-76 was introduced into the Gab1 cDNA by site directed mutagenesis using a commercial kit (Clontech). The yeast two-hybrid interactions from transformants of at least two independent experiments were quanti®ed using the b-galactosidase liquid assay (Chien et al., 1991) .
Cell culture and protein complex formation inhibition
The human embryonic kidney cell line HEK293 (ATCC) was cultured in DMEM with 10% FBS and antibiotics. Jurkat (human T) cells were grown in RPMI1640 with 10% FBS and antibiotics. 293 cell lysates were made on ice by washing cells three times with ice-chilled PBS with 1 mM Na 2 EDTA and subsequent lysis with RIPA 100 (20 mM TrisHCl pH 7.5, 0.1% sodium dodecylsulfate, 0.5% deoxycholate, 1% Triton X-100, 100 mM NaCl, 1 mM dithiothreitol) containing an extra high concentration of protease inhibitors to minimize the degradation of the Gab1 protein: 10 mM Na 2 EDTA, 10 mM EGTA, 10 mg/ml Aprotinin, 0.2 mM phenylmethylsulfonyl¯uoride, 0.5 mg/ml Leupeptin (51867, Serva), 5 mg/ml Antipain dihydrochloride (A-6191, Sigma), 0.7 mg/ml Pepstatin A (1524488, Roche), 26 concentrated protease inhibitor cocktail (Complete, 1697498, Roche) . After clari®cation of the lysates by centrifugation at 10 0006g for 30 min, the supernatants were frozen as aliquots in liquid nitrogen and stored at 7808C until used. Jurkat cell lysates were made using the same procedure, except for the initial harvest prior to lysis when cells were pelleted by centrifugation (10 min 7006g) and washed once with chilled PBS with 1 mM Na 2 EDTA.
pGEX-vectors encoding GST-fusion proteins of human Grb2 full length, Grb2 SH2, Grb2 SH3(N) and Grb2 SH3(C) have been described previously (Pendergast et al., 1993; Feller et al., 1995a; Oehrl et al., 1998) . GST-fusion proteins were expressed and glutathione-sepharose puri®ed according to standard procedures and after elution with 100 mM glutathione dialyzed three times with 1000 volumes 5 mM TrisHCl pH 7.5.
For in vitro inhibition of protein complex formation, 20 mg of GST or an equimolar amount of the indicated GST-tagged fusion proteins were mixed with 400 ml IP buer (20 mM TrisHCl, pH 7.5, 1 mM Na 2 EDTA, 100 mM NaCl, 5% glycerol, 0.1% Tween 20, 1 mM dithiotreitol and inhibitors as described above), glutathione-sepharose beads, 1 ± 2 mg human cell protein extract and peptides as indicated. After mixing, samples were incubated for 90 min at 48C. The precipitates were washed three times with RIPA 100 buer. After SDS ± PAGE and semi-dry blotting, Gab1, SLP-76, cCbl or SoS bound to GST-fusion proteins was detected with the corresponding antisera: anti-SoS (S15520, Transduction Laboratories), anti-Gab1 (sc-6292, goat, Santa Cruz), anti-SLP-76 (S60720, Transduction Laboratories) or anti-c-Cbl (sc-170, rabbit, Santa Cruz). Detection was with HRPcoupled secondary antibodies and ECL.
Purification of recombinant Gab1 and protein complex formation with GST-SH3 fusion proteins
A His-tagged and N-terminally truncated murine Gab1 protein with a deletion of the pleckstrin homology (PH) domain was expressed in E. coli (pET, NovaBlue; Novagene) since we were unsuccessful to obtain the full length protein in sucient quality. PH domains have no known SH3 domain binding capacity and are modular structures which are unlikely to strongly in¯uence the overall folding of a protein.
Puri®cation was done with Ni
2+
-agarose (Ni-NTA; Quiagen) according to standard protocols.
In the precipitation experiments 8 mg of Gab1DPH protein was mixed with 20 mg of GST or an equimolar amount of the GST-SH3 fusion proteins indicated plus 15 ml glutathionesepharose beads in IP buer (total volume per precipitation 250 ml) supplemented with 1 mg/ml of soluble E. coli extract. The E. coli protein extract was made by boiling bacterial pellets with 1% SDS, followed by extensive dialysis of the extract against PBS and subsequent 10 0006g centrifgation to remove precipitated proteins. After a 2 h incubation at 48C on a nutator, samples were washed twice with RIPA 100 buer. Precipitated Gab1DPH protein was detected by SDS ± PAGE and blotting with anti-Gab1.
To con®rm the functionality of the GST-Grb2 SH3(N) fusion protein, 35 S-labeled Grb2 SH3 proteins were prepared as previously described (Feller et al., 1995b) . The purity and 35 S-labeling of the GST-SH3 proteins was con®rmed by SDS ± PAGE and Coomassie-staining, followed by autoradiography. Thirty mg of nonlabeled GST-SH3(N) was mixed with 15 ml glutathione-sepharose beads and 1 mg of total RIPA 100 extract of HEK293 cells, incubated 1 h at 48C on a nutator and then washed 26 with RIPA 100. After SDS ± PAGE and blotting, proteins were renatured and detected with the 35 S-labeled Grb2 SH3(N) protein probe (®nal concentration 10 mg/ml) as previously described in detail (Feller et al., 1995b) . After autoradiography, the membrane was reprobed with anti-SoS and anti-Cbl as indicated.
